Skip to main content
. 2020 Jul 8;16(3):347–366. doi: 10.1007/s11302-020-09711-4

Fig. 1.

Fig. 1

Pyrimidine metabolism signaling pathway is highly enriched in lung cancer. a Table showed the detailed GEO datasets and TCGA datasets used in this study. b Enrichment plots demonstrated the enriched pyrimidine metabolism signaling pathway in GSE7670, GSE10072, GSE18842, GSE19188, GSE27262, GSE30219, GSE31210, GSE31908, GSE33532, GSE75324, and TCGA LUAD, LUSC datasets. Enrichment of normalized enrichment score (NES) and P values were presented. LUAD: lung adenocarcinoma; LUSC: lung squamous cell carcinoma;